瘤微环境中的CCL20:对癌症进展和治疗方法的影响
Louis Boafo Kwantwi1, James Danquah Boafo2, Bevelyn Emefa Egleh3,4
1Department of Biomedical Sciences, College of Medicine, Northeast Ohio Medical University, Rootstown, OH, 44272, USA. lkwantwi@neomed.edu.
概括
CCL20-CCR6轴通过创建免疫抑制瘤微环境来推动瘤的进展. 针对这一轴为新型癌症疗法提供了一个有前途的战略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 瘤微环境 (TME) 在癌症进展中起着至关重要的作用.
- 在TME中溶解的因素调节免疫细胞相互作用,促进瘤生长.
- 新的基于免疫的疗法正在出现,因为人们对免疫抑制性TME的理解越来越大.
研究的目的:
- 审查CCL20-CCR6轴在瘤微环境中的作用.
- 为了阐明CCL20-CCR6相互作用如何促进瘤进展.
- 探索针对癌症中CCL20-CCR6轴的治疗策略.
主要方法:
- 对CCL20,CCR6和瘤微环境研究的文献综述.
- 对癌症中CCL20-CCR6信号的分子机制的分析.
- 综合关于CCL20-CCR6对瘤增殖,血管生成,转移和免疫抑制的影响的数据.
主要成果:
- CCL20,一种化学激素及其受体CCR6是TME的关键调解者.
- CCL20-CCR6轴促进瘤扩散,血管新生,转移和免疫抑制.
- 这个轴有助于各种癌症的治疗耐药性.
结论:
- CCL20-CCR6轴是通过TME调制促进瘤进展的重要驱动因素.
- 准CCL20-CCR6轴为癌症治疗提供了一个潜在的治疗途径.
- 涉及CCL20抑制的组合疗法与标准治疗一起显示出有前途.
相关概念视频
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
02:40Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K